Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses

Journal of Clinical Investigation

Volumn 118, Issue 3, 2008, Pages 1017-1026

  Ahlenstiel, Golo ^a   Martin, Maureen P ^b   Gao, Xiaojiang ^b   Carrington, Mary ^b   Rehermann, Barbara ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVITY; CELL KINETICS; CELL MATURATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENOTYPE; HLA SYSTEM; HOMOZYGOSITY; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS A; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION;

CELL DEGRANULATION; FEMALE; GENOTYPE; HLA-C ANTIGENS; HUMANS; INFLUENZA A VIRUS; INTERFERON TYPE II; KILLER CELLS, NATURAL; MALE; RECEPTORS, KIR;

EID: 40549084319     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32400     Document Type: Article

References (81)